multiple sclerosis
According to a recent study, the gut microbiota could determine remittance or pro-inflammatory conditions in multiple sclerosis.
GDP-L-fucose synthase, a protein produced by bacteria often found in the gut of people with MS, triggers an autoimmune response from T-cells in MS patients.
